PTPRC and neoplasm: However, it is entirely possible to administer fluorescently labeled antibodies systemically prior to imaging.[27] Given the importance of quantitating immune cells during tumor treatments, we chose CD45 to stain host cells in the tumor microenvironment for ≈5 min.